RootPath Genomics: Funding, Investors & Team (Sep 2026)
RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. Their next generation technologies allow us to precisely monitor, modulate and steer the immune system for a revolution in the diagnosis and treatment of cancer.
RootPath Genomics has raised $50.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Apr 2025.
RootPath Genomics Company Profile and Key Stats
Latest funding round on record: Apr 2025.
RootPath Genomics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
RootPath Genomics raised $50.0M in a Series B announced in Sep 2021.
3.6 years later, an undisclosed round was announced in Apr 2025 with no disclosed amount.
RootPath Genomics Founders and Leadership Team
Contact details for the RootPath Genomics team: 1 of 1 has an email address on file.
Start 14-day free trial →RootPath Genomics Funding Compared to Other Biotechnology Startups
Funded Startups Like RootPath Genomics in Biotechnology and Cambridge
Companies Similar to RootPath Genomics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
RootPath Genomics Funding FAQs
What does RootPath Genomics do?
RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. Their next generation technologies allow us to precisely monitor, modulate and steer the immune system for a revolution in the diagnosis and treatment of cancer.
How much funding has RootPath Genomics raised?
RootPath Genomics has raised $50.0M across 2 rounds on record.
When did RootPath Genomics last raise funding?
RootPath Genomics' most recent funding round on record was announced in Apr 2025. The amount was not disclosed.
Who founded RootPath Genomics?
FundedIQ lists Xi Chen (Founder) at RootPath Genomics.
Where is RootPath Genomics headquartered?
RootPath Genomics is based in Cambridge, Massachusetts, United States.
How many employees does RootPath Genomics have?
RootPath Genomics is in the 11-50 employee band.
About FundedIQ's RootPath Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RootPath Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.